ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 (ASMB) Institutional Ownership

CUSIP: 045396108

13F Institutional Holders and Ownership History from Q3 2014 to Q1 2024

Type / Class
Equity / Common Stock, par value $0.001
Symbol
ASMB on Nasdaq
Shares outstanding
15,535,831
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 045396108?
CUSIP 045396108 identifies ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 (ASMB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GILEAD SCIENCES, INC. 29% -3% 4,505,391 +104% GILEAD SCIENCES, INC. 08 Aug 2025

Institutional Holders of ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 (ASMB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q1 0 $0 -$7,090,883 0
2023 Q4 8,647,319 $7,090,909 -$888,258 $0.82 42
2023 Q3 9,538,435 $8,441,336 -$822,987 $0.88 32
2023 Q2 10,465,062 $12,032,628 -$1,413,281 $1.15 31
2023 Q1 12,058,487 $10,132,844 -$2,696,808 $0.84 37
2022 Q4 14,193,683 $18,446,999 -$3,479,618 $1.30 38
2022 Q3 16,595,417 $27,215,067 -$1,058,512 $1.64 47
2022 Q2 17,189,015 $36,094,086 -$3,856,015 $2.10 51
2022 Q1 19,078,839 $39,299,944 -$9,004,415 $2.06 52
2021 Q4 23,096,231 $53,810,453 -$9,786,082 $2.33 57
2021 Q3 22,706,616 $79,015,136 -$15,483,325 $3.48 61
2021 Q2 27,092,112 $105,110,485 -$6,950,361 $3.88 87
2021 Q1 27,158,674 $124,930,551 +$3,461,631 $4.60 102
2020 Q4 26,661,326 $161,302,039 -$148,788,454 $6.05 106
2020 Q3 30,096,975 $494,769,297 +$965,633 $16.44 115
2020 Q2 29,993,173 $700,372,173 +$25,372,004 $23.32 103
2020 Q1 28,961,280 $429,566,715 +$7,108,278 $14.83 96
2019 Q4 28,128,251 $575,504,046 +$162,191,719 $20.46 99
2019 Q3 20,717,323 $203,852,941 -$9,083,327 $9.83 96
2019 Q2 21,081,214 $285,953,531 -$38,445,831 $13.49 105
2019 Q1 22,086,821 $435,072,882 +$11,598,737 $19.69 100
2018 Q4 21,336,229 $482,552,988 -$22,408,761 $22.62 105
2018 Q3 21,451,389 $796,704,124 +$177,939,690 $37.14 110
2018 Q2 16,619,055 $651,643,809 +$19,143,017 $39.21 103
2018 Q1 16,057,360 $789,004,865 +$27,408,726 $49.14 105
2017 Q4 15,553,324 $703,758,442 +$144,330,948 $45.25 96
2017 Q3 12,365,961 $431,475,805 -$9,930,754 $34.92 71
2017 Q2 12,545,320 $258,622,356 +$12,681,076 $20.65 64
2017 Q1 11,915,179 $301,467,000 +$19,729,899 $25.49 49
2016 Q4 11,664,156 $140,277,170 +$7,379,773 $12.15 36
2016 Q3 11,111,633 $79,350,000 -$991,944 $7.21 35
2016 Q2 11,282,629 $61,880,000 -$5,130,215 $5.55 42
2016 Q1 12,398,866 $61,573,000 -$829,366 $5.02 45
2015 Q4 12,345,854 $92,315,823 -$1,081,570 $7.51 48
2015 Q3 12,381,895 $118,371,122 -$281,444 $9.56 50
2015 Q2 12,067,730 $232,422,915 +$27,421,764 $19.26 57
2015 Q1 10,760,000 $142,462,000 +$85,107,581 $13.24 31
2014 Q4 4,299,218 $33,460,000 +$10,957,571 $7.86 22
2014 Q3 1,641,550 $13,446,000 +$13,446,000 $8.19 19